Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels
<i>Background:</i> Antifibrotic agents have been approved for the treatment of idiopathic pulmonary fibrosis (IPF). However, the efficacy of these drugs in the treatment of familial IPF (FIPF) has not been previously reported. <i>Case presentation:</i> We report the case of a...
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
MDPI AG
2019-05-01
|
| 叢編: | Medicina |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/1010-660X/55/5/161 |